JNJ
Johnson & Johnson
ACTIONABLEMethodology gates passed
Position levels
Currenttoday
USD 259.24
Buy <=wait / entry
USD 235.00
Trim >=take some off
USD 275.00
Thesis breakJohnson & Johnson cutting 2026 reported sales guidance below USD 95 billion, a h...
-
Scenario-weighted conviction
| Probability | Score | Contribution | |
|---|---|---|---|
| Bull case | 30% | 100 / 100 | 30.0 |
| Base case | 52% | 62 / 100 | 32.2 |
| Bear case | 18% | 10 / 100 | 1.8 |
| Weighted conviction | 64 / 100 - OPPORTUNISTIC BUY | ||
Top risks
- Q2 earnings beat with sales of $25.31B and raised full-year sales guidance to $101.1B midpoint
- Raised adjusted EPS guidance to $11.68 midpoint from $11.55
- 2024 Shockwave Medical acquisition for $13.1B